1-10 of 10
Authors: J Kollmeier
Save search
Sort by
Journal Article

DES16C3cje: A low-luminosity, long-lived supernova Free

PDF
C P Gutiérrez and others
Monthly Notices of the Royal Astronomical Society, Volume 496, Issue 1, July 2020, Pages 95–110, https://doi.org/10.1093/mnras/staa1452
Published: 25 May 2020
Journal Article

1499PPembrolizumab as first-line treatment in NSCLC with PD-L1 ≥50%: Real life results from an all-comer population Free

PDF
N Frost and others
Annals of Oncology, Volume 30, Issue Supplement_5, October 2019, mdz260.021, https://doi.org/10.1093/annonc/mdz260.021
Published: 01 October 2019
Journal Article

1672PMaintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study Free

PDF
M Thomas and others
Annals of Oncology, Volume 29, Issue suppl_8, October 2018, mdy298.008, https://doi.org/10.1093/annonc/mdy298.008
Published: 23 October 2018
Journal Article

Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study Open Access

PDF
M Thomas and others
Annals of Oncology, Volume 29, Issue 10, October 2018, Pages 2076–2084, https://doi.org/10.1093/annonc/mdy326
Published: 20 August 2018
Journal Article

1527OTop-line data from the randomized phase 2 IMPULSE study in small-cell lung cancer (SCLC): Immunotherapeutic maintenance treatment with lefitolimod Get access

PDF
M. Thomas and others
Annals of Oncology, Volume 28, Issue suppl_5, September 2017, mdx386, https://doi.org/10.1093/annonc/mdx386
Published: 18 September 2017
Journal Article

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial Get access

PDF
P. Christopoulos and others
Annals of Oncology, Volume 28, Issue 8, August 2017, Pages 1898–1902, https://doi.org/10.1093/annonc/mdx268
Published: 23 May 2017
Journal Article

Immune surveillance reactivation to improve overall survival in small cell lung cancer (SCLC): The randomized IMPULSE study Get access

PDF
M. Thomas and others
Annals of Oncology, Volume 27, Issue suppl_6, 1 October 2016, 1432TiP, https://doi.org/10.1093/annonc/mdw389.10
Published: 11 October 2016
Journal Article

14TiPImmunomodulatory switch maintenance therapy to improve overall survival in small cell lung cancer (SCLC): The randomized IMPULSE study Get access

PDF
M. Thomas and others
Annals of Oncology, Volume 26, Issue suppl_8, November 2015, Page viii6, https://doi.org/10.1093/annonc/mdv514.04
Published: 18 November 2015
Journal Article

1071PCHEMOIMMUNOTHERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) WITH IMPRIME PGG (IPGG) IN COMBINATION WITH CETUXIMAB, CARBOPLATIN AND PACLITAXEL–ANALYSIS OF SECONDARY ENDPOINTS OF A MULTICENTER, RANDOMIZED PHASE 2 TRIAL Get access

PDF
F. Schneller and others
Annals of Oncology, Volume 25, Issue suppl_4, September 2014, Page iv369, https://doi.org/10.1093/annonc/mdu342.24
Published: 01 September 2014
Journal Article

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study Get access

PDF
M. Kreuter and others
Annals of Oncology, Volume 24, Issue 4, April 2013, Pages 986–992, https://doi.org/10.1093/annonc/mds578
Published: 15 November 2012